Assessment of Utility of Lycopene, Selenium, and Vitamin E in Management of Oral Leukoplakia.
Lycopene
oral leukoplakia
selenium
vitamin E
Journal
Journal of pharmacy & bioallied sciences
ISSN: 0976-4879
Titre abrégé: J Pharm Bioallied Sci
Pays: India
ID NLM: 101537209
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
09
01
2022
revised:
02
02
2022
accepted:
07
02
2022
entrez:
16
9
2022
pubmed:
17
9
2022
medline:
17
9
2022
Statut:
ppublish
Résumé
To assess the utility of lycopene, selenium, and vitamin E in the management of leukoplakia. In this cross-sectional observational prospective study, 52 patients of oral leukoplakia were divided into 2 groups. Group I patients were prescribed 6 mg of lycopene, 400 I.U. of vitamin E, and 200 μg of selenium twice a day. Group II patients were prescribed a placebo capsule. The clinical improvement was recorded in both groups. The mean pretreatment size of lesion in group I was 9.24 cm The treatment with a combination of lycopene, selenium, and vitamin E is useful and effective in managing the cases of oral leukoplakia.
Identifiants
pubmed: 36110830
doi: 10.4103/jpbs.jpbs_63_22
pii: JPBS-14-233
pmc: PMC9469266
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S233-S235Informations de copyright
Copyright: © 2022 Journal of Pharmacy and Bioallied Sciences.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Nutr. 2005 Mar;135(3):363-6
pubmed: 15735064
J Nutr. 1989 Jan;119(1):116-22
pubmed: 2643694
JAMA. 1997 May 7;277(17):1380-6
pubmed: 9134944
Oral Oncol. 2004 Jul;40(6):591-6
pubmed: 15063387
Int Dent J. 1960 Sep;10:350-67
pubmed: 13782659
J Dent Educ. 2002 Aug;66(8):896-902
pubmed: 12214837